Chronic Inhibition of Complement C1s By TNT009 Produces Sustained, Complete Remission in Patients with Severe, Transfusion-Dependent Cold Agglutinin Disease (CAD)

被引:2
|
作者
Jilma, Bernd [1 ]
Gilbert, James C. [2 ]
Panicker, Sandip [2 ]
Parry, Graham C. [2 ]
Fillitz, Michael [3 ]
Thomas, Schenk [4 ]
Sillaber, Christian [5 ]
Bartko, Johann [1 ]
Jaeger, Ulrich [6 ]
机构
[1] Med Univ Vienna, Dept Clin Pharmacol, Vienna, Austria
[2] True North Therapeut Inc, San Francisco, CA USA
[3] Hanusch Hosp, Vienna, Austria
[4] Univ Klinikum St Polten, Internal Med, St Polten, Austria
[5] Med Univ Vienna, Div Hematol, Dept Internal Med 1, Vienna, Austria
[6] Med Univ Vienna, Div Hematol & Hemostaseol, Vienna, Austria
关键词
D O I
10.1182/blood.V128.22.2435.2435
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
2435
引用
收藏
页数:4
相关论文
共 22 条
  • [21] SUTIMLIMAB, A COMPLEMENT C1S INHIBITOR, IMPROVES QUALITY OF LIFE IN PATIENTS WITH COLD AGGLUTININ DISEASE: PATIENT-REPORTED OUTCOMES RESULTS OF THE PHASE 3 CARDINAL STUDY
    Barcellini, W.
    Roth, A.
    Tvedt, T. H. Anderson
    Miyakawa, Y.
    Kuter, D. J.
    Hobbs, W.
    Su, J.
    Jiang, X.
    Morales Arias, J.
    Weitz, I. C.
    HAEMATOLOGICA, 2021, 106 (10) : 111 - 112
  • [22] C1s-targeted inhibition of classical complement pathway by sutimlimab in cold agglutinin disease (CAD): Efficacy and safety results from the randomized, placebo (PBO)-controlled phase 3 CADENZA study
    Roth, A.
    Berentsen, S.
    Barcellini, W.
    D'Sa, S.
    Jilma, B.
    Michel, M.
    Weitz, I. C.
    Yamaguchi, M.
    Nishimura, J., I
    Vos, J. M., I
    Patel, P.
    Schaible, B.
    Jiang, X.
    Vagge, D. S.
    Wardecki, M.
    Shafer, F.
    Lee, M.
    Broome, C. M.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 40 - 41